歡迎光臨源葉生物,登錄 | 注冊 |
當前位置: 首頁 > 小分子抑制劑 > Immunology/Inflammation > Iguratimod

瀏覽歷史

S82530

Iguratimod

源葉(MedMol) 99%
  • 英文名:
  • Iguratimod
  • 別名:
  • N-(3-甲酰氨基-4-氧-6-苯氧基-4H-色滿-7-基)甲烷磺酰胺; N-[3-(甲酰胺基)-4-氧-6-苯氧基-4H-1-苯并吡喃-7-基]甲烷磺酰胺; N-[7-(甲烷磺酰氨基)-4-氧-6-苯氧基-4H-色滿-3-基]甲酰胺;;N-(3-Formamido-4-oxo-6-phenoxy-4H-chromen-7-yl)methanesulfonamide; N-[7-(Methanes
  • CAS號:
  • 123663-49-0
  • 分子式:
  • C17H14N2O6S
  • 分子量:
  • 374.37
  • 核磁/質(zhì)譜:
品牌貨號產(chǎn)品規(guī)格價格(RMB) 庫存(上海) 北京 武漢 南京 數(shù)量計量單位 加入購物車...
源葉(MedMol) S82530-5mg 99% ¥80.00元 >10 - - - EA 加入購物車
源葉(MedMol) S82530-10mg 99% ¥120.00元 >10 - - - EA 加入購物車
源葉(MedMol) S82530-50mg 99% ¥400.00元 >10 - - - EA 加入購物車
大包裝詢價

提交您的電話號碼并同意《個人信息授權(quán)與保護申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻

質(zhì)檢證書(COA)

摩爾濃度計算器

相關(guān)產(chǎn)品

  • 提示:詳情請下載說明書。
  • 產(chǎn)品描述: Iguratimod is an antirheumatic agent, acts as an inhibitor of COX-2, with an IC50 of 20 μM (7.7 μg/mL), but shows no effect on COX-1. Iguratimod also inhibits macrophage migration inhibitory factor (MIF) with an IC50 of 6.81 μM.
  • 靶點: COX-2:20 μM (IC50);MIF:6.81 μM (IC50);Others;?COX
  • 體內(nèi)研究:
    Iguratimod (5 or 20 mg/kg) shows analgesic effect, significantly improves the pain withdrawal threshold of the left hind paw in dose-dependent manner in rats. Iguratimod (5 or 20 mg/kg) reduces the elevation of pERK1/2 and c-Fos in the spinal cord induced by cancer cell inoculation. Iguratimod also dose-dependently decreases the IL-6 levels in rats. In Iguratimod-treated rats, the activity of osteoclasts is weaker than the control group. Iguratimod (20 mg/kg i.p.) shows significantly increased survival in BALB/c mice that are vulnerable to endotoxemia, and attenuates TNFα release measured in serum isolated 90 min post-LPS administration in wild-type C57BL/6 mice
  • 參考文獻:
    1. Tanaka K, et al. T-614, a novel antirheumatic drug, inhibits both the activity and induction of cyclooxygenase-2 (COX-2) in cultured fibroblasts. Jpn J Pharmacol. 1995 Apr;67(4):305-14. 2. Sun Y, et al. Anti-rheumatic drug iguratimod protects against cancer-induced bone pain and bone destruction in a rat model. Oncol Lett. 2017 Jun;13(6):4849-4856. 3. Iguratimod, et al. Identification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-sparing Potential. J Biol Chem. 2016 Dec 16;291(51):26502-26514.
  • 溶解性: DMSO  :  33.33  mg/mL  (89.03  mM;  Need  ultrasonic)
  • 保存條件: -20℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 2.671 ml 13.356 ml 26.712 ml
    5 mM 0.534 ml 2.671 ml 5.342 ml
    10 mM 0.267 ml 1.336 ml 2.671 ml
    50 mM 0.053 ml 0.267 ml 0.534 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號:

本計算器可幫助您計算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:


質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學研究,銷售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷售條款。